Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Adimab announced the expansion of an earlier multi-target research agreement with Regeneron Pharmaceuticals.
read more
Tuesday, October 20, 2020
Bora Pharmaceuticals announced its Chairman and CEO, Bobby Sheng, was unveiled as ‘CEO of the Year’ at the CPhI Pharma Awards 2020.
read more
Ricerca Biosciences, an integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, announces Dr. G. Lynn Miesel as the new technical director.
read more
Capsugel's offering combines its proprietary Xcelodose® Precision Powder Micro-Dosing Systems with industry-leading powder-in-capsule/powder-in-bottle (PIC/PIB) expertise developed at Xcelience, which Capsugel acquired in January.
read more
Wednesday, December 10, 2025
ProRx Pharma announced a major expansion of its operations with the addition of new clean rooms, automation, and robotic technologies.
read more
Andelyn Biosciences and ENCell announced the signing of a Collaboration Agreement to establish a strategic manufacturing bridge between the United States and Asia-Pacific (APAC) regions to accelerate the global delivery of gene therapies.
read more
Cambrex announced that it has opened a new 120m2 quality control (QC) laboratory at its site in Paullo, Milan, Italy.
read more
The makers of the potent painkiller OxyContin have pulled out of a federal meeting to review the company's harder-to-abuse version of the much-debated drug.
read more
ChemConnection, a privately-held company manufacturing nanomedicines, bioconjugates, peptides, and small molecules, announces the successful GMP production of CriPec® docetaxel for its customer Cristal Therapeutics, a privately-held life sciences ...
read more
Wednesday, October 19, 2016
FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research. Misconduct in clinical research, including, but not limited to the falsification ...
read more
Tuesday, November 24, 2020
Samsung Biologics' partnership with Eli Lilly and Company is expected to accelerate the global supply for Lilly's COVID-19 antibody therapies through a long-term manufacturing agreement.
read more
Thursday, February 28, 2019
Bioinfogate has entered into a global agreement with Clarivate Analytics to cross-link the OFF-X translational safety intelligence portal with Cortellis preclinical intelligence.
read more
Genovac, a contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for therapeutic, diagnostic and research market segments, and ENPICOM, a bioinformatics software engineering company, ...
read more
Fluxergy is making a $30 million investment to expand its capability to scale production of the Fluxergy Analyzer diagnostic testing system in response to the COVID-19 pandemic.
read more
Wednesday, October 28, 2020
Vanessa Research has been granted positive orphan drug opinion by the EMA for their drug Shylicine.
read more